From Alchemy to IPO: The Business of Biotechnology

by Cynthia Robbins - Roth (Author)

• Used

  Paperback
  2001

  $4.13

  A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth. -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can. -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, AmgenWritten by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry-biotechnology-that's on the verge of living up to its monumental promise to change the world as we know it.

• Used

  Hardcover
  2000

  $3.27

  A fascinating glimpse inside the life-and-death business of biotechnology.. It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. From Alchemy to IPO presents the dramatic story of the revolutionary and controversial business of inventing new cures and blockbuster drugs and a look at how biotech progress is generating powerful profit opportunities on all tiers of business and investment.Written by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the '70s to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market, and describes advances, such as deciphering the genetic code and gene therapy, that just may lead biotech to a higher realm altogether. This is the first book to accurately record the inner workings of an industry-biotechnology-that's on the verge of living up to its monumental promise to change the world as we know it.

• New

  Paperback
  2001

  $24.75

  A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth. -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can. -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, AmgenWritten by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry-biotechnology-that's on the verge of living up to its monumental promise to change the world as we know it.